Edited by a team of the world’s leading interventional
cardiologists and educators, this new book is created with an eye
to giving the reader a solid, practical, and clinically focused
understanding of this important class of drugs, from basic science
to a clear-headed discussion of complex topics such as combination
therapies, drug-to-drug interactions, and resistance to
antiplatelet agents.
This important new book:
* Begins with a concise but thorough discussion of platelet
biology and pathophysiology so that readers understand how
antiplatelet agents work and why they produce such a varied range
of complications, from minor GI upset to potentially
life-threatening conditions such as neutropenia, a critical
shortage of white blood cells.
* Thoroughly covers platelet function testing, including novel
techniques.
* Clarifies current best practice regarding the use of
antiplatelet agents in both chronic and acute cardiovascular
disease.
* Reviews all types of antiplatelet agents – from aspirin
to recently approved drugs – including indications, clinical
outcomes, and side effects.
Written by an international ‘who’s who’ of
experts in the field, Antiplatelet Therapy in Cardiovascular
Disease also includes an entire section covering the use of
antiplatelet drugs in PCIs, including percutaneous valve repair,
which makes this text particularly essential to interventional
cardiologists.
cardiologists and educators, this new book is created with an eye
to giving the reader a solid, practical, and clinically focused
understanding of this important class of drugs, from basic science
to a clear-headed discussion of complex topics such as combination
therapies, drug-to-drug interactions, and resistance to
antiplatelet agents.
This important new book:
* Begins with a concise but thorough discussion of platelet
biology and pathophysiology so that readers understand how
antiplatelet agents work and why they produce such a varied range
of complications, from minor GI upset to potentially
life-threatening conditions such as neutropenia, a critical
shortage of white blood cells.
* Thoroughly covers platelet function testing, including novel
techniques.
* Clarifies current best practice regarding the use of
antiplatelet agents in both chronic and acute cardiovascular
disease.
* Reviews all types of antiplatelet agents – from aspirin
to recently approved drugs – including indications, clinical
outcomes, and side effects.
Written by an international ‘who’s who’ of
experts in the field, Antiplatelet Therapy in Cardiovascular
Disease also includes an entire section covering the use of
antiplatelet drugs in PCIs, including percutaneous valve repair,
which makes this text particularly essential to interventional
cardiologists.
€73.99
เกี่ยวกับผู้แต่ง
Ron Waksman, MD, FACC, is Associate Director, Division of Cardiology and Director of Experimental Angioplasty & New Technologies, Washington Hospital Center, Washington, DC. Dr. Waksman is currently the Editor-in-Chief of Cardiovascular Revascularization Medicine and sits on the editorial boards of six other internationally published journals. He has been Editor/Co-Editor of six books since 1996 and has authored 22 additional book chapters. Dr. Waksman has also authored/co-authored over 250 published manuscripts and over 200 abstracts. He is also a Clinical Professor of Medicine (Cardiology) at Georgetown University, Washington, DC, USA.
ภาษา อังกฤษ ● รูป PDF ● หน้า 352 ● ISBN 9781118494011 ● ขนาดไฟล์ 9.9 MB ● บรรณาธิการ Ron Waksman & Paul A. Gurbel ● สำนักพิมพ์ John Wiley & Sons ● การตีพิมพ์ 2014 ● ฉบับ 1 ● ที่สามารถดาวน์โหลดได้ 24 เดือน ● เงินตรา EUR ● ID 2994578 ● ป้องกันการคัดลอก Adobe DRM
ต้องใช้เครื่องอ่านหนังสืออิเล็กทรอนิกส์ที่มีความสามารถ DRM
หนังสืออิเล็กทรอนิกส์เพิ่มเติมจากผู้แต่งคนเดียวกัน / บรรณาธิการ
140,061 หนังสืออิเล็กทรอนิกส์ในหมวดหมู่นี้
